Trump tariff hunt eyes India's last stock market refuge but it won't be an easy kill
Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite India's strong presence in the US generics market, potential tariffs may increase costs for US consumers and create supply chain challenges.
For more details: Click here